Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
15.65
-0.55 (-3.40%)
At close: Sep 12, 2025, 4:00 PM EDT
15.66
+0.01 (0.06%)
After-hours: Sep 12, 2025, 5:27 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $945.28 million as of September 12, 2025. Its market cap has decreased by -33.08% in one year.
Market Cap
945.28M
Enterprise Value
418.70M
1-Year Change
-33.08%
Ranking
Category
Stock Price
$15.65
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $945.28M, an increase of 746.26%. That is a compound annual growth rate of 25.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 945.30M | -21.05% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |